Provided by Tiger Trade Technology Pte. Ltd.

Sonoma Pharmaceuticals, Inc.

1.22
-0.0100-0.81%
Post-market: 1.16-0.0600-4.92%19:30 EDT
Volume:37.33K
Turnover:45.42K
Market Cap:5.84M
PE:-1
High:1.23
Open:1.23
Low:1.20
Close:1.23
52wk High:4.45
52wk Low:0.8501
Shares:4.79M
Float Shares:4.77M
Volume Ratio:0.79
T/O Rate:0.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2200
EPS(LYR):-1.8854
ROE:-42.52%
ROA:-5.37%
PB:0.89
PE(LYR):-0.65

Loading ...

Sonoma Pharmaceuticals - Enters Section 382 Rights Agreement with Computershare on Oct 6, 2026 - SEC Filing

THOMSON REUTERS
·
Yesterday

Sonoma Pharmaceuticals - Each Right Entitles Holder to Purchase 1/1000th Series B Preferred Stock for $10 - SEC Filing

THOMSON REUTERS
·
Yesterday

Sonoma Pharmaceuticals Annual Meeting Draws 2,082,799 Shares Represented by Proxy

Reuters
·
Sep 17

Sonoma Pharmaceuticals Special Shareholder Meeting Lacked Quorum, Chairman Canceled Session

Reuters
·
Aug 20

Sonoma Pharmaceuticals - Cancels Special Meeting Due to Lack of Quorum - SEC Filing

THOMSON REUTERS
·
Aug 20

Sonoma Pharmaceuticals Q1 Operating Expenses USD 2.6 Million

Reuters
·
Aug 06

Sonoma Pharmaceuticals Q1 Revenue Rises on US Growth

Reuters
·
Aug 06

Sonoma Pharmaceuticals Q1 Gross Profit USD 2.6 Million

THOMSON REUTERS
·
Aug 06

Sonoma Pharmaceuticals Q1 EPS $(0.09) Up From $(0.76) YoY, Sales $6.406M Up From $4.015M YoY

Benzinga Earnings
·
Aug 06

Sonoma Pharmaceuticals Turns EBITDA Positive for First Time with Record Quarterly Revenue

Benzinga Earnings
·
Aug 06

Sonoma Pharma FY27 Q1 Net Loss Narrows 73.41% to USD 330,000; Revenue Rises 60% to USD 6.41 Million

Reuters
·
Aug 06

Sonoma Pharmaceuticals Announces Annual Shareholder Meeting

Reuters
·
Jul 29

Sonoma Pharma Wins FDA 510(k) Clearance Expanding Microdacyn Wound Solution Indications

Reuters
·
Jun 30

Sonoma Pharma ups at-the-market stock offering to $3.64 million

Reuters
·
Jun 19

Sonoma Pharmaceuticals - Increases Maximum Aggregate Offering Price of Common Stock to $3.64 Mln - SEC Filing

THOMSON REUTERS
·
Jun 19

Sonoma Pharmaceuticals Q4 revenue rises 48% on US growth

Reuters
·
Jun 17

Sonoma Pharmaceuticals Q4 EPS $(0.33) Misses $(0.24) Estimate, Sales $5.561M Miss $5.565M Estimate

Benzinga Earnings
·
Jun 17

BRIEF-Sonoma Pharmaceuticals Q4 Net Income USD -600 Thousand

Reuters
·
Jun 17

Sonoma Pharmaceuticals Q4 Ebitda USD -200 Thousand

THOMSON REUTERS
·
Jun 17

Sonoma Pharmaceuticals FY26 net loss narrows to $3.18 million; revenue rises 37% to $19.53 million

Reuters
·
Jun 17